Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia. (2017)

First Author: Huang B
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2017.08.073

PubMed Identifier: 28827201

Publication URI: http://europepmc.org/abstract/MED/28827201

Type: Journal Article/Review

Volume: 531

Parent Publication: International journal of pharmaceutics

Issue: 1

ISSN: 0378-5173